Grant, Karen M. (2008) Targeting the Cell Cycle in the Pursuit of Novel Chemotherapies against Parasitic Protozoa. Current Pharmaceutical Design, 14 (9). pp. 917-924. ISSN 1873-4286Full text not available from this repository.
Protozoan parasites, such as those responsible for malaria and African Sleeping Sickness, represent a huge burden to the developing world. Current chemotherapy to combat these diseases is inadequate: antiquated, toxic and increasingly ineffective due to drug resistance. In this article, the potential usefulness of targeting key regulators of the parasite cell cycle will be discussed, paying particular attention to three families of protein kinases: Cyclin-dependent kinases, glycogen synthase kinases and Aurora kinases. This review shall outline their identification, which has been greatly accelerated by the availability of parasite genome data, their validation as bona fide regulators of the parasite cell cycle and current data on the availability and anti-parasite activity of inhibitors.
|Journal or Publication Title:||Current Pharmaceutical Design|
|Uncontrolled Keywords:||Cyclin-dependent kinase Glycogen synthase kinase Aurora kinase cell cycle Trypanosoma Leishmania Plasmodium|
|Subjects:||R Medicine > RM Therapeutics. Pharmacology|
|Departments:||Faculty of Health and Medicine > Medicine|
|Deposited By:||Dr Karen Grant|
|Deposited On:||05 Sep 2008 11:14|
|Last Modified:||22 Feb 2017 01:10|
Actions (login required)